TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy August 7, 1981